TARA-002 selected for FDA manufacturing development and readiness pilot program. NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- ...

This month, I’ll share some of the free software I use to understand how TV signals make it from the transmitter to the ...

Lymphatic malformations (LMs) are congenital vascular anomalies characterized by abnormal lymphatic development, leading to ...

New York-based clinical-stage cancer and rare diseases drug developer Protara Therapeutics today announced that the US Food ...

After a shaky start to 2025, the S&P 500 rallied to close out a third consecutive year of above-average gains for the index. The S&P 500 still finished the year up more than 16% ...

Protara Therapeutics (TARA) announced that the U.S. Food and Drug Administration has granted both Breakthrough Therapy and Fast Track designations ...

Southeast Cancer Support Services is closing out its first full year of operation with major milestones reached and a growing ...